RSS Feeds
Search

Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Brentuximab Vedotin – First Treatment Option for Relapsed Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma (Subset of Non-Hodgkin Lymphoma)
May 2011 - 5 pages - $500
Accelerating Lead Generation
Jun 2009 - 175 pages - $3,835
Lymphoma - Pipeline Review, Q3 2011
Jul 2011 - 672 pages - $500
Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 4th Edition
Jun 2010 - 160 pages - $3,995
The Drug Discovery Outsourcing Market
Jan 2011 - 99 pages - $3,835
Mantle Cell Lymphoma - Pipeline Review, Q3 2011
Jul 2011 - 268 pages - $500
Follicular Lymphoma - Pipeline Review, Q3 2011
Jul 2011 - 213 pages - $500
Early Stage Drug Discovery in Disease Segments - Innovation Focuses on Stem Cell Therapies and Gene Therapies
Feb 2011 - 209 pages - $3,500
CombinatoRx Incorporated: Premium Company Profile
Dec 2007 - 46 pages - $495
Lymphoma Therapy Area Pipeline Report
Nov 2010 - 233 pages - $1,495
More Related Market Research Reports >>>

Your selection

Industry sector
Drug discovery del
High throughput screening del
Therapeutic target
Oncology del
Lymphoma del
Neoplastic disease del
Year
2000 del

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us